LDN Social Media
Get connected with us on social networks
Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information.
Dr. Holtorf discusses what further tests can be done to aid in diagnosis, when to consider nonstandard thyroid preparations, when to use straight T3, when to use T4, immune modulator therapy such as LDN and peptides, and how they're very synergistic and beneficial to prevent and reverse chronic illness.
Peptides regulate most every known system in the body to be homeostatic, that may become unbalanced with illness, age, stress, chronic infection, dieting, obesity, diabetes, or any disease of aging. He talks about other labs to show immune dysfunction, and where thyroid and immune modulation is needed. He presents a study that almost all chronic fatigue syndrome and fibromyalgia patients are low thyroid despite normal thyroid function tests. Many things result in low tissue levels of thyroid, but the TSH is normal.
Having low-normal thyroid has a higher risk to health than hypercholesterolemia, hypertension, diabetes, and or smoking. Several treatment approaches are given, with cautions about timed-release thyroid formulas. Case studies, and published studies are presented.
KEYWORDS: Lyme, Hashimoto’s, thyroid, autoimmune, obesity, depression, fibromyalgia, chronic fatigue syndrome, diabetes, immune, pituitary, hormone, anxiety, stress, pregnancy, PMS, osteoporosis, atrial fibrillation, peptides, stem cells, hypercoagulability, migraines, EMF, pain, traumatic brain injury, neurodegenerative diseases, dementia, inflammatory bowel disease, traumatic brain injury, ADHD, OCD, mold, dry eyes, autism, pediatric, cortisol, mast cell
This is a summary of the presentation. Click on the video for full information.